Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Insulet Reports Fourth Quarter and Full Year 2016 Financial Results
Fourth Quarter Revenue of $103.6 Million , up 24% Year-Over-Year; Full Year 2016 Revenue of $367.0 Million , up 39% Year-Over Year, Exceeds Expectations Fourth Quarter Gross Margin Improves to 58.8%; Full Year 2016 Gross Margin Improves to 57.5% Insulet Expects Full Year 2017 Revenue Growth of
View HTML
Toggle Summary Insulet Presents Strong Omnipod® Horizon™ Hybrid Closed-Loop Study Results at ATTD in Paris
First Feasibility Study on the Automated Glucose Control Algorithm Demonstrates Beneficial Results in Adults with Type 1 Diabetes BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®
View HTML
Toggle Summary Insulet Completes Acquisition of U.S. Manufacturing Facility in Acton, Massachusetts
Facility to Support Long-Term Growth Initiatives While Driving Increased Productivity and Quality BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today
View HTML
Toggle Summary Insulet Corporation to Present at Upcoming Investor Conferences
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences: The Cowen and Company
View HTML
Toggle Summary Insulet Corporation to Announce Fourth Quarter and Full Year 2016 Financial Results on February 27, 2017
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full year 2016
View HTML
Toggle Summary Insulet Corporation to Present at Upcoming Investor Conference
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the 35 th Annual J.P.
View HTML
Toggle Summary Insulet Celebrates Milestone of 100,000 Customers Actively Using the Omnipod® System
During National Diabetes Awareness Month, Insulet honors Omnipod users and reinforces commitment to help make living with diabetes easier BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its
View HTML
Toggle Summary Insulet to Webcast Investor Day on November 16, 2016
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced it will host an Investor Day on November 16, 2016 , in Boston, Massachusetts .
View HTML
Toggle Summary Insulet Reports Third Quarter 2016 Financial Results
Third Quarter Revenue of $94.9 Million , up 33% Year-Over-Year, Exceeds Expectations Gross Margin Improves to 58.6% Company Raises Full Year 2016 Revenue Guidance to a Range of $362 to $365 million , from $345 to $355 million ; Approximately 38% Year-Over-Year Growth at Mid-Point BILLERICA, Mass.
View HTML
Toggle Summary New Study Shows Majority of Omnipod® Insulin Management System Users Report Significant Clinical and Quality of Life Benefits
Data Published in Diabetes Technology & Therapeutics Demonstrates Improved A1c Levels, Patients' Well-Being, and Perceived Control over Diabetes BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with
View HTML
Toggle Summary Insulet Corporation Honors National Diabetes Awareness Month at the NASDAQ Stock Market Closing Bell Ceremony on November 1st
Activities Highlight Insulet's Commitment to Raising Awareness of Diabetes BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today
View HTML
Toggle Summary Insulet Announces Board and Management Changes
Patrick Sullivan Elected Chairman of the Board Jessica Hopfield , PhD, Assumes Role of Lead Independent Director Shacey Petrovic Promoted to President and Chief Operating Officer Daniel Levangie Announces Retirement BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet
View HTML
Toggle Summary Insulet Corporation to Announce Third Quarter 2016 Financial Results on November 3, 2016
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation ( NASDAQ : PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the third quarter of 2016 on November 3, 2016
View HTML
Toggle Summary Insulet Enrolls First Patients in Clinical Trial for its Omnipod® Artificial Pancreas System
Study Brings Insulet Another Step Closer to Providing its Omnipod ® Horizon ™ Hybrid Closed Loop System to People with Diabetes BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®
View HTML
Toggle Summary Insulet Announces Pricing of Convertible Senior Notes Due 2021
Proceeds for General Corporate Purposes, Including Repurchase of a Portion of Outstanding 2% Convertible Senior Notes Due 2019 and Investment in Manufacturing and Supply Chain BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  ( NASDAQ : PODD) (Insulet or the Company), a leader in tubeless
View HTML